The percentage of CD4 T regulatory cells do not differ between patients and controls, but their function is compromised (maturation and migration) (51) and the transcription factor FoxP3, crucial for the function of regulatory T-cells, has been reported to be diminished in RRMS patients (52). This evidence concerns the gene FOXP3 and relapsing-remitting multiple sclerosis.